October 25, 2012 — Immuneering’s CEO (Ben Zeskind, PhD, MBA) will moderate a plenary session at the 4th Translational Medicine Conference, and give a talk entitled “Predicting Response and Understanding…
Read More
The article “Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study” by de Groot et al1 was published in Journal of Clinical Oncology….
Clinical Cancer Research recently published an important study by Coward and colleagues (1) examining interleukin-6 as a target in ovarian cancer and last year published an investigation of the same…
Supported by the Office of International Affairs, National Cancer Institute (NCI), the “US-Japan Workshop on Immunological Biomarkers in Oncology” was held in March 2009. The workshop was related to a…
The International Society for the Biological Therapy of Cancer (iSBTc) has initiated in collaboration with the United States Food and Drug Administration (FDA) a programmatic look at innovative avenues for…
